A new battery technology provides double the energy storage at lower cost than the batteries that are used in handheld electronics, electric vehicles, aerospace and defence.

A software tool which uses quantum mechanics to allow designers to predict the properties of materials has reached the commercial milestone of $30 million in sales.

More than £1 billion in funding has been raised by companies with roots in Cambridge research, according to year-end results from Cambridge Enterprise, the University’s commercialisation arm.

A team from the Centre for Smart Infrastructure and Construction has developed a mechanical amplifier which converts ambient vibrations into electricity more effectively, and could be used to power wireless sensors for monitoring the structural health of roads, bridges and tunnels.

Promising new technique for creating stem cells using a routine blood sample.

Cambridge team which developed method to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.

A series of programmes which aim to address and counteract radical thought in British youth is now being adapted for use across Europe.

A new collaboration based at the University of Cambridge will aim to discover and develop new medicines to treat liver disease.

A new technology which delivers sustained release of therapeutics for up to six months could be used in conditions which require routine injections, including diabetes, certain forms of cancer and potentially HIV/AIDS.

By using thorium instead of uranium as fuel, nuclear power could be safer and more sustainable, according to new research.